Ohira Masayuki, Takano Ai, Yoshi Kentaro, Arai Akira, Aso Yashuhiro, Furutani Rikiya, Hamano Tadanori, Takahashi-Iwata Ikuko, Kaneko Chikako, Matsuura Tohru, Maeda Norihisa, Nakajima Hideto, Shindo Katsuro, Suenaga Toshihiko, Sugie Kazuma, Suzuki Yasuhiro, Yamashita Toru, Angulo Frederick J, Edwards Juanita, Bender Cody Matthew, Harper Lisa R, Nakayama Yoshikazu, Ito Shuhei, Pilz Andreas, Stark James H, Moïsi Jennifer C, Mizusawa Hidehiro, Takao Masaki
Department of Clinical Laboratory and Internal Medicine, National Center of Neurology and Psychiatry, Tokyo, Japan.
Department of Veterinary Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Eur J Neurol. 2025 Jan;32(1):e70005. doi: 10.1111/ene.70005.
Clinical manifestations of Lyme borreliosis (LB), caused by Borrelia burgdorferi sensu lato (Bbsl), include erythema migrans, Lyme neuroborreliosis (LNB), carditis, and arthritis. LB is a notifiable disease in Japan with <30 surveillance-reported LB cases annually, predominately from Hokkaido Prefecture. However, LB, including LNB, may be under-diagnosed in Japan since diagnostic tests are not readily available. We sought to determine if LNB could be a cause of previously undiagnosed encephalitis or meningitis in Japan.
Investigators at 15 hospitals in 10 prefectures throughout Japan retrieved serum and/or cerebrospinal fluid (CSF) samples collected in 2010-2021 from 517 patients hospitalized with encephalitis or meningitis which had an etiology that had not been determined. Samples were tested for Bbsl-specific antibodies using ELISA and Western blot tests. In alignment with the European Union LNB case definition, a confirmed LNB case had CSF pleocytosis and intrathecal production of Bbsl-specific antibodies and a probable LNB case had a CSF sample with pleocytosis and Bbsl-specific antibodies.
LNB was identified in three hospitalized patients with meningitis of previously undetermined etiology: a male resident of Aomori Prefecture was a confirmed LNB case, and two female residents of Oita Prefecture were probable LNB cases. None of the patients with confirmed or probable LNB had traveled in the month prior to symptom onset and none had samples previously tested for LB.
The identification of previously undiagnosed LNB cases indicates a need for enhanced disease awareness in Japan, particularly beyond Hokkaido Island, and more readily available LB diagnostic testing.
由伯氏疏螺旋体狭义种(Bbsl)引起的莱姆病(LB)的临床表现包括游走性红斑、莱姆神经疏螺旋体病(LNB)、心脏炎和关节炎。LB在日本是须报告的疾病,每年监测报告的LB病例<30例,主要来自北海道地区。然而,由于诊断检测不易获得,LB,包括LNB,在日本可能未得到充分诊断。我们试图确定LNB是否可能是日本先前未诊断的脑炎或脑膜炎的病因。
日本10个县15家医院的研究人员检索了2010 - 2021年期间从517例因脑炎或脑膜炎住院且病因未明的患者中采集的血清和/或脑脊液(CSF)样本。使用酶联免疫吸附测定(ELISA)和蛋白质印迹试验检测样本中的Bbsl特异性抗体。根据欧盟LNB病例定义,确诊的LNB病例脑脊液有细胞增多且鞘内产生Bbsl特异性抗体,可能的LNB病例脑脊液样本有细胞增多且有Bbsl特异性抗体。
在3例先前病因未明的脑膜炎住院患者中发现了LNB:青森县一名男性居民为确诊的LNB病例,大分县两名女性居民为可能的LNB病例。确诊或可能为LNB的患者在症状出现前一个月均未出行,且之前均未进行过LB检测。
发现先前未诊断的LNB病例表明日本需要提高对该病的认识,特别是在北海道岛以外地区,并且需要更易于获得的LB诊断检测。